PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
 
J Clin Invest. 1964 November; 43(11): 2204–2213.
PMCID: PMC442008

Action of Complement in Hereditary Angioneurotic Edema: The Role of C′1-Esterase *

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.7M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • HAGY GW, DANHOF I. Genetic and physiological aspects of a family with chronic hereditary lymphedema (Nonne-Milroy-Meige's disease) and hereditary angioneurotic edema. Am J Hum Genet. 1958 Jun;10(2):141–153. [PubMed]
  • TRIGG JW. Hereditary angioneurotic edema. Report of a case with gastrointestinal manifestations. N Engl J Med. 1961 Apr 13;264:761–763. [PubMed]
  • LANDERMAN NS. Hereditary angioneurotic edema. I. Case reports and review of the literature. J Allergy. 1962 Jul-Aug;33:316–329. [PubMed]
  • DONALDSON VH, EVANS RR. A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. Am J Med. 1963 Jul;35:37–44. [PubMed]
  • HEINER DC, BLITZER JR. Familial paroxysmal dysfunction of the autonomic nervous system (a periodic disease), often precipitated by emotional stress. Pediatrics. 1957 Nov;20(5 Pt 1):782–793. [PubMed]
  • RATNOFF OD, LEPOW IH. COMPLEMENT AS A MEDIATOR OF INFLAMMATION. ENHANCEMENT OF VASCULAR PERMEABILITY BY PURIFIED HUMAN C'1 ESTERASE. J Exp Med. 1963 Nov 1;118:681–698. [PMC free article] [PubMed]
  • Pillemer L, Ecker EE. THE TERMINOLOGY OF THE COMPONENTS OF COMPLEMENT. Science. 1941 Nov 7;94(2445):437–437. [PubMed]
  • LEPOW IH, RATNOFF OD, PILLEMER L. Elution of an esterase from antigen-antibody aggregates treated with human complement. Proc Soc Exp Biol Med. 1956 May;92(1):111–114. [PubMed]
  • BECKER EL. Concerning the mechanism of complement action. II. The nature of the first component of guinea pig complement. J Immunol. 1956 Dec;77(6):469–478. [PubMed]
  • RATNOFF OD, LEPOW IH. Some properties of an esterase derived from preparations of the first component of complement. J Exp Med. 1957 Aug 1;106(2):327–343. [PMC free article] [PubMed]
  • LEPOW IH, RATNOFF OD, LEVY LR. Studies on the activation of a proesterase associated with partially purified first component of human complement. J Exp Med. 1958 Mar 1;107(3):451–474. [PMC free article] [PubMed]
  • HAINES AL, LEPOW IH. STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES. J Immunol. 1964 Mar;92:456–467. [PubMed]
  • LEPOW IH, NAFF GB, TODD EW, PENSKY J, HINZ CF. Chromatographic resolution of the first component of human complement into three activities. J Exp Med. 1963 Jun 1;117:983–1008. [PMC free article] [PubMed]
  • MULLER-EBERHARD HJ, KUNKEL HG. Isolation of a thermolabile serum protein which precipitates gamma-globulin aggregates and participates in immune hemolysis. Proc Soc Exp Biol Med. 1961 Feb;106:291–295. [PubMed]
  • TARANTA A, WEISS HS, FRANKLIN EC. Precipitating factor for aggregated gamma-globulins in normal human sera. Nature. 1961 Jan 21;189:239–240. [PubMed]
  • HAINES AL, LEPOW IH. STUDIES ON HUMAN C'1-ESTERASE. III. EFFECT OF RABBIT ANTI-C'1-ESTERASE ON ENZYMATIC AND COMPLEMENT ACTIVITIES. J Immunol. 1964 Mar;92:479–490. [PubMed]
  • LEVY LR, LEPOW IH. Assay and properties of serum inhibitor of C'l-esterase. Proc Soc Exp Biol Med. 1959 Aug-Sep;101:608–611. [PubMed]
  • PENSKY J, LEVY LR, LEPOW IH. Partial purification of a serum inhibitor of C'1-esterase. J Biol Chem. 1961 Jun;236:1674–1679. [PubMed]
  • LEPOW IH, WURZ L, RATNOFF OD, PILLEMER L. Studies on the mechanism of inactivation of human complement by plasmin and by antigen-antibody aggregates. I. The requirement for a factor resembling C'1 and the role of Ca++. J Immunol. 1954 Sep;73(3):146–158. [PubMed]
  • LEPOW IH, PILLEMER L. Studies on the mechanism of inactivation of human complement by plasmin and by antigen-antibody aggregates. II. Demonstration of two distinct reaction stages in complement fixation. J Immunol. 1955 Jul;75(1):63–70. [PubMed]
  • LEON MA. Quantitative studies on the properdin-complement system. J Exp Med. 1956 Mar 1;103(3):285–293. [PMC free article] [PubMed]
  • KENT JF, OTERO AG, HARRIGAN RE. Relative specificity of serologic tests for syphilis in Mycobacterium leprae infection. Am J Clin Pathol. 1957 May;27(5):539–545. [PubMed]
  • NAFF GB, PENSKY J, LEPOW IH. THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT. J Exp Med. 1964 Apr 1;119:593–613. [PMC free article] [PubMed]
  • MARTIN RG, AMES BN. A method for determining the sedimentation behavior of enzymes: application to protein mixtures. J Biol Chem. 1961 May;236:1372–1379. [PubMed]
  • HAINES AL, LEPOW IH. STUDIES ON HUMAN C'1-ESTERASE. II. FUNCTION OF PURIFIED C'1-ESTERASE IN THE HUMAN COMPLEMENT SYSTEM. J Immunol. 1964 Mar;92:468–478. [PubMed]
  • GRABAR P, WILLIAMS CA. Méthode permettant l'étude conjuguée des proprietés électrophorétiques et immunochimiques d'un mélange de protéines; application au sérum sanguin. Biochim Biophys Acta. 1953 Jan;10(1):193–194. [PubMed]
  • MUELLER-EBERHARD HJ, BIRO CE. ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT. J Exp Med. 1963 Sep 1;118:447–466. [PMC free article] [PubMed]
  • Rapp HJ, Borsos T. Complement and Hemolysis. Science. 1963 Aug 23;141(3582):738–740. [PubMed]
  • MULLER-EBERHARD HJ, NILSSON U, ARONSSON T. Isolation and characterization of two beta1-glycoproteins of human serum. J Exp Med. 1960 Feb 1;111:201–215. [PMC free article] [PubMed]
  • LANDERMAN NS, WEBSTER ME, BECKER EL, RATCLIFFE HE. Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein. J Allergy. 1962 Jul-Aug;33:330–341. [PubMed]
  • HOLDSTOCK DJ, MATHIAS AP, SCHACHTER M. A comparative study of kinin, kallidin, and bradykinin. Br J Pharmacol Chemother. 1957 Jun;12(2):149–158. [PubMed]
  • WEBSTER ME, PIERCE JV. The nature of the kallidins released from human plasma by kallikreins and other enzymes. Ann N Y Acad Sci. 1963 Feb 4;104:91–107. [PubMed]
  • ELLIOTT DF, HORTON EW, LEWIS GP. Actions of pure bradykinin. J Physiol. 1960 Oct;153:473–480. [PubMed]
  • BHOOLA KD, CALLE JD, SCHACHTER M. The effect of bradykinin, serum kallikrein and other endogenous substances on capillary permeability inthe guinea-pig. J Physiol. 1960 Jun;152:75–86. [PubMed]
  • MILES AA, WILHELM DL. Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. I. An activable permeability factor and its inhibitor in guinea-pig serum. Br J Exp Pathol. 1955 Feb;36(1):71–81. [PubMed]
  • WEBSTER ME, PIERCE JV. Action of the kallikreins on synthetic ester substrates. Proc Soc Exp Biol Med. 1961 May;107:186–191. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation